PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Beijing Institute of Radiation Medicine, Beijing 100850, PR China. sqwang@bmi.ac.cn and College of Life Sciences, Anhui Agricultural University, Hefei 230036, PR China.\', \'National Institutes for Food and Drug Control, Beijing 100050, PR China.\', \'The General Hospital of Northern Theater Command, Shenyang 110016, PR China.\', \'Division of Liver Diseases, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang 050021, China. daieh2008@126.com.\', \'Beijing Institute of Radiation Medicine, Beijing 100850, PR China. sqwang@bmi.ac.cn.\', \'Beijing Institute of Radiation Medicine, Beijing 100850, PR China. sqwang@bmi.ac.cn and Beijing Key Laboratory of New Molecular Diagnosis Technologies for Infectious Disease, Beijing 100850, PR China. rongzhen0525@sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1039/d1an00304f
?:hasPublicationType
?:journal
  • The Analyst
is ?:pmid of
?:pmid
?:pmid
  • 33970172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.249
?:rankingScore_hIndex
  • 129
is ?:relation_isRelatedTo_publication of
?:title
  • Development of spike protein-based fluorescence lateral flow assay for the simultaneous detection of SARS-CoV-2 specific IgM and IgG.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all